Top Markets
Coin of the day
Aspire Biopharma Holdings, Inc. Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc.

ASBP
Peringkat dalam Saham #38720
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise... Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
Harga Saham
$7.28
Kapitalisasi Pasar
$839.91K
Perubahan (1 hari)
2.39%
Perubahan (1 tahun)
-98.44%
Negara
US
Perdagangan Aspire Biopharma Holdings, Inc. (ASBP)

Kategori

Riwayat hasil dividen untuk Aspire Biopharma Holdings, Inc. (ASBP)
Hasil dividen (TTM) dari Aspire Biopharma Holdings, Inc. (simbol saham: ASBP) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Aspire Biopharma Holdings, Inc. (ASBP) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing